Skip to Main Content

Browse issues

The Journal of Infectious Diseases Cover Image for Volume 228, Issue 3
Volume 228, Issue 3
1 August 2023
ISSN 0022-1899
EISSN 1537-6613

Volume 228, Issue 3, 1 August 2023

Editorial Commentary

Cornelius J Clancy and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 225–226, https://doi.org/10.1093/infdis/jiad129

Major Articles and Brief Reports

Special Article on Publishing Standards

Emmanuel A Zavalis and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 227–234, https://doi.org/10.1093/infdis/jiad130

An evaluation of 5340 articles published in 9 specialty infectious disease journals in 2019 and 2021 showed code sharing, data sharing, registration, and conflicts of interest and funding disclosures in 3%, 11%, 8%, 79%, and 92%, respectively; transparency can be improved.

Covid-2019 Disease Pathogenesis

Derek E Dimcheff and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 235–244, https://doi.org/10.1093/infdis/jiad061

In this large study of hospitalized patients, RNA viral loads were similar, regardless of infecting variant and known risk factors for severe COVID.

Visa Nurmi and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 245–250, https://doi.org/10.1093/infdis/jiad070

Outcomes of 2 clinical SARS-CoV-2 convalescent plasma treatment trials, one effective the other ineffective, were not explained by serological markers of the convalescent plasma used. Start of treatment in relation to disease progression was likely the key factor that determined success.

Nanina Anderegg and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 251–260, https://doi.org/10.1093/infdis/jiad074

Population-based, whole genome sequencing (WGS) of SARS-CoV-2 produces additional information for routine epidemiological contact tracing data to support public health decision making. Household transmission was not confirmed by WGS data in many cases.

Lin Tang and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 261–269, https://doi.org/10.1093/infdis/jiad090

China-produced inactivated COVID-19 absolute vaccine effectiveness (VE) levels against Omicron BA.2 infection, pneumonia or worse, and severe COVID-19 were 17%, 66%, and 91%; boosted VEs were 22%, 74%, and 93%. Inactivated vaccines were highly effective against severe COVID-19 in China's then infection-naive population.

HIV/Aids

M Ali Rai and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 270–275, https://doi.org/10.1093/infdis/jiad096

We describe the immunologic and virologic impact of monkeypox infection in a woman with human immunodeficiency virus receiving antiretroviral therapy. Extensive phenotypic analyses of B and T cells and biomarkers showed significant immunologic perturbations despite mild monkeypox infection.

Jake A Robinson and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 276–280, https://doi.org/10.1093/infdis/jiad105

Simian immunodeficiency virus (SIV) infection leads to interferon and microbial pathogen-associated signaling in the heart. Antiretrovirals dampen inflammatory signaling. Chronic SIV infection treated with antiretrovirals reduces expression of genes associated with fatty acid metabolism in the heart.

Ciputra Adijaya Hartana and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 281–286, https://doi.org/10.1093/infdis/jiad173

IL-8–secreting CD4 T cells are inversely correlated with HIV-1 reservoir size at birth in vertically infected neonates; these CD4 T cells may therefore represent a barrier against HIV-1 reservoir seeding.

Viral Disease Pathogenesis

Justin R Ortiz and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 287–298, https://doi.org/10.1093/infdis/jiad021

In a multicenter controlled human infection model study, we inoculated 76 participants with influenza A/California/04/2009/H1N1pdm-like virus and safely achieved a 71.1% attack rate of mild-to-moderate influenza disease. High virus-specific hemagglutination inhibition and microneutralization titers were associated with protection from illness.

Zourab Bebia and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 299–310, https://doi.org/10.1093/infdis/jiad024

In this phase 2 observer-blind, placebo-controlled, randomized clinical trial, RSVPreF3 maternal vaccination during late second or third trimester had an acceptable safety risk profile and induced robust RSV-specific immune responses with successful antibody transfer to their newborns.

Jaiprasath Sachithanandham and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 311–320, https://doi.org/10.1093/infdis/jiad025

Structured plasma measurements and single-cell characterization in liver demonstrate that second-phase plasma viral kinetics derive directly from reductions in HCV-infected hepatocytes after initiating treatment with direct-acting antivirals and confirms that treatment leads to loss of HCV RNA from infected hepatocytes.

Bacterial Disease Pathogenesis

JooHee Choi and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 321–331, https://doi.org/10.1093/infdis/jiad187

Comparative genomics of 175 Mycobacterium abscessus isolates reveal nonrandom parallel mutations in 22 genes. We demonstrate altered macrolide susceptibility co-occurring with a nonsynonymous whiB1 mutation and the loss of a 23-kb mercury-resistance plasmid during M. abscessus in-host adaptation.

Zhicheng Hu and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 332–342, https://doi.org/10.1093/infdis/jiad046

In Staphylococus aureus bacteremia mouse model, aging and TLR2 deficiency impair the immune responses in distinct patterns. Mortality was more controlled by aging, whereas weight loss and kidney abscess were more TLR2 dependent. Aging increased mortality independent of TLR2 expression.

Michelle C Sabo and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 343–352, https://doi.org/10.1093/infdis/jiad050

Mortality from tuberculous meningitis remains unacceptably high. This is the first study to show an association between tuberculous meningitis susceptibility and mortality and a polymorphism in MUC5AC, which is an important gel-forming mucin expressed in lungs.

Aminul Islam and others
The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Pages 353–363, https://doi.org/10.1093/infdis/jiad069

Multi-drug resistant Acinetobacter baumannii causes dangerous infections in immunocompromised patients. Rag2−/− mice were highly susceptible to A. baumannii infection, but could be treated prophylactically with serum or gamma globulins from uninfected mice, implicating natural antibodies in infection resistance.

Correction

The Journal of Infectious Diseases, Volume 228, Issue 3, 1 August 2023, Page 364, https://doi.org/10.1093/infdis/jiad143
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close